Dr David Conen is a cardiologist, scientist and principal investigator at the Population Health Institute at McMaster University in Hamilton, Canada.
Dr Conen is Principal Investigator of two major international trials studying the treatment and prevention of atrial fibrillation – the COP-AF and ASPIRE-AF Trials.
